CD34 and acute myeloid leukemia: In human AML, several studies showed that LSCs can share certain cell-surface markers that are used to define normal HSCs, including non-expression of lineage (Lin) markers, expression of the CD34 surface marker, and a CD38 negative (CD38-) immunophenotype.